share_log

藥明康德：於2024年第一季度 2019年A股激勵計劃調整後 首次授予第三個行權期 授出的部分股票期權行權

WUXI APPTEC: EXERCISE OF PART OF THE SHARE OPTIONS GRANTED UNDER THE ADJUSTED INITIAL GRANT OF THE 2019 A SHARE INCENTIVE PLAN FOR THE THIRD VESTING PERIOD DURING THE FIRST QUARTER OF 2024

香港交易所 ·  Apr 1 07:27
Summary by Moomoo AI
無錫藥明康德於2024年第一季度完成2019年A股激勵計劃第三個行權期的部分股票期權行權。該行權期自2023年6月27日至2024年5月25日，共有276名激勵對象參與行權。行權後，公司A股股份總數減少19,864,508股，H股股份減少15,467,500股。此次股票期權行權的股票來源為公司向激勵對象定向發行的新A股普通股。公司股權結構變動後，實際控制人保持不變。董事會成員包括執行董事李革博士等人，並於2024年4月1日由董事長李革博士發布公告。
無錫藥明康德於2024年第一季度完成2019年A股激勵計劃第三個行權期的部分股票期權行權。該行權期自2023年6月27日至2024年5月25日，共有276名激勵對象參與行權。行權後，公司A股股份總數減少19,864,508股，H股股份減少15,467,500股。此次股票期權行權的股票來源為公司向激勵對象定向發行的新A股普通股。公司股權結構變動後，實際控制人保持不變。董事會成員包括執行董事李革博士等人，並於2024年4月1日由董事長李革博士發布公告。
In the first quarter of 2024, Wuxi Pharmaceutical Company completed a partial stock option on the third stock option under the 2019 A-share incentive plan. From 27 June 2023 to 25 May 2024, 276 incentive holders participated in the exercise. After the exercise, the total number of Company A shares decreased by 19,864,508 shares and the H shares decreased by 15,467,500 shares. The stock for this stock option exercise is derived from the Company's issuance of new A Shares Ordinary Shares aimed at incentive targets. After the company's equity structure changes, the actual controller remains unchanged. The members of the Board of Directors include Dr. Li Keung, Executive Director, etc., and an announcement was made on April 1, 2024 by the Chairman, Dr. Li Keung.
In the first quarter of 2024, Wuxi Pharmaceutical Company completed a partial stock option on the third stock option under the 2019 A-share incentive plan. From 27 June 2023 to 25 May 2024, 276 incentive holders participated in the exercise. After the exercise, the total number of Company A shares decreased by 19,864,508 shares and the H shares decreased by 15,467,500 shares. The stock for this stock option exercise is derived from the Company's issuance of new A Shares Ordinary Shares aimed at incentive targets. After the company's equity structure changes, the actual controller remains unchanged. The members of the Board of Directors include Dr. Li Keung, Executive Director, etc., and an announcement was made on April 1, 2024 by the Chairman, Dr. Li Keung.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more